Dermatology Perspective

• Non-Pharmacologic Therapies in PsO and PsA: 5 Things to Know While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial role in enhancing treatment outcomes and improving patients' quality of life.
  Medscape Rheumatology, April 01, 2025
• Gene Therapy: Medical Progress Has a Price, Says Ethicist   Ethicist Art Caplan discusses progress in gene therapy research and the need for medical professionals and regulators to tolerate appropriate risk.
  Medscape Business of Medicine, April 01, 2025
• AAD 2025 HS Highlights From the AAD 2025 Annual Meeting   Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or emergency department visits, and takeaways on optimizing use of HS therapies.
  Medscape, March 31, 2025
• AAD 2025 Urticaria Highlights From AAD 2025   Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody placulumab, and positive results from the phase 3 studies of remibrutinib.
  Medscape, March 31, 2025
• AAD 2025 Atopic Dermatitis Highlights From AAD 2025   Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.
  Medscape, March 31, 2025
• AAD 2025 Applying Key Lessons on HS From AAD 2025 to the Clinic   Dr. Christopher J. Sayed shares insights on the growing emphasis on personalized care for hidradenitis suppurativa.
  Medscape, March 28, 2025
• Medscape Dermatologists and Suicide Report 2025 Dermatologists reveal whether they, or colleagues, have contemplated suicide. They also discuss factors behind the suicide issue and where doctors can turn for help.
  Medscape Features Slideshows, March 28, 2025
• The Ethical Consequences of the New Administration   Ethicist Art Caplan discusses the ethical consequences of the new administration.
  Medscape Business of Medicine, March 27, 2025
• AAD 2025 New Hope for CSU: Applying Key Insights From AAD 2025   Dr Adam Friedman discusses the clinical impact of CSU updates, highlighting emerging therapies, dietary insights, and patient care strategies.
  Medscape, March 27, 2025
• Who Really Needs Treatment? The Biomarker Challenge   Dr Teresa Amaral discusses considerations for avoiding treatment of patients with stage II melanoma.
  Medscape Oncology, March 27, 2025
• AAAAI 2025 Urticaria, Angioedema, and Anaphylaxis Highlights From AAAAI   The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at AAAAI and discussed by Dr Ruchi Gupta.
  Medscape, March 24, 2025
• European Doctors’ Sexual Harassment Report 2025 Healthcare systems in Europe still have far to go if they aim to keep doctors safe in the workplace.
  Medscape Features Slideshows, March 24, 2025
• The Space to Listen In medicine, we learn to see what's visible—lesions, symptoms, signs. Mrs. Miller taught me to look for what isn't: the hidden lives that patients carry with them.
  Medscape Dermatology, March 21, 2025
• AAAAI 2025 AAAAI/WAO 2025: The Impact of Advancements in Allergy Care   Dr Ruchi Gupta reflects on the clinical implications of key highlights, including new CSU treatments, food allergy advances, and upcoming epinephrine options.
  Medscape, March 21, 2025
• Refining Melanoma Treatment With Biomarker-Driven Insights   Dr. Teresa Amaral highlights the vital role of biomarkers in assessing melanoma risk and guiding personalized treatment decisions.
  Medscape Oncology, March 20, 2025
• Ethicist Supports Assisted-Suicide Policies—With Safeguards   Ethicist Art Caplan discusses considerations regarding assisted-suicide laws.
  Medscape Business of Medicine, March 20, 2025
• S3 Episode 2: For Psoriasis, Should Dermatologists Treat Obesity?   Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
  Medscape, March 18, 2025
• S3 Episode 1: Cost, Coverage, and Psoriasis: Overcoming Care Barriers   Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.
  Medscape, March 18, 2025
• GLP-1s Are Crazy Effective — Just Not Cost-Effective   We know they are expensive, but isn’t the cost recouped by the healthcare savings? Dr F. Perry Wilson explains.
  Medscape, March 17, 2025
• AAD 2025 AAD 2025: New Excitement Around Hidradenitis Suppurativa   Dr Christopher J. Sayed describes how AAD 2025 showcased exciting advancements in hidradenitis suppurativa treatment.
  Medscape, March 17, 2025